Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer
This study is ongoing, but not recruiting participants.
Astellas Pharma Inc
Medivation is now a wholly owned subsidiary of Pfizer Inc.
Information provided by (Responsible Party):
First received: June 26, 2013
Last updated: December 20, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||June 2017|
|Primary Completion Date:||March 2015 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||March 21, 2016|